Changxin Technology updates prospectus, Country Garden misses 30 billion.

TL;DR

• Changxin Technology (CXMT) updated its prospectus on May 17, reporting Q1 2026 revenue of 50.8 billion yuan (up 719.13% year-on-year) and net profit of 24.762 billion yuan (up 1,688%), marking a significant turnaround from its 2025 cumulative loss of 36.65 billion yuan.
• Valuation of Changxin Technology is expected to surge from its pre-IPO level of nearly 300 billion yuan to approximately 2 trillion yuan, based on latest financial performance and peer P/E ratios.
• Country Garden (Biguiyuan) lost out on a potential 30 billion yuan return by selling its 1.56% stake in Changxin Technology for 2 billion yuan (approx. 1.07x return on 900 million yuan invested) in December 2024 to address liquidity crises.
• The sale of stakes in hard-tech assets like Changxin, Blue Arrow Space, and Dreame Technology was forced by Country Garden's severe cash flow issues and the strategic shift to "cash is king" amidst a 32.835 billion yuan loss in 2024.
• Country Garden’s venture capital arm has scaled down investments sharply since 2022 (from 17 to 3 deals in 2025) but retains over 10 billion yuan in equity value across remaining hard-tech holdings.

Why It Matters

This case highlights the critical strategic divergence between distressed real estate developers and high-growth semiconductor companies, illustrating how liquidity constraints can force the premature divestment of high-value tech stakes. It serves as a stark risk management lesson for corporate venture capital (CVC) units, showing that holding high-beta tech assets can become a source of significant opportunity cost if the parent company’s core business deteriorates. For AI and semiconductors, the explosive growth of domestic DRAM leaders underscores the sector’s massive valuation re-rating and its importance in the global supply chain.

Key Data

• Changxin Technology Q1 2026 Financials: Revenue of 50.8 billion yuan (YoY +719.13%) and Net Profit of 24.762 billion yuan (YoY +1,688%).
• Valuation Comparison: Pre-IPO valuation near 300 billion yuan vs. estimated new valuation of approximately 2 trillion yuan based on current earnings.
• Country Garden Exit Terms: Sold 1.56% stake in Changxin for 2 billion yuan at 2.22 yuan/share; potential value at new estimate is over 30 billion yuan (approx. 30x missed return).
• Country Garden 2024 Performance: Net loss of 32.835 billion yuan; equity contract sales dropped from 174.3 billion yuan to 47.2 billion yuan.
• Current Stock Price: Country Garden stock price at 0.255 HKD.

Technical Details

• Changxin Technology Structure: The company is China's largest integrated device manufacturer (IDM) for DRAM chips, holding the first position in production capacity in China and fourth globally.
• Global Market Context: Global DRAM market is dominated by Samsung, SK Hynix, and Micron with over 90% combined share; Changxin represents the emerging domestic alternative with rapidly scaling capacity.
• Country Garden CVC Portfolio: Managed by Shenzhen Biguiyuan Innovation Investment (registered 2019), the fund focuses on semiconductors, new energy, AI, and biomedicine. It has invested in over 90 companies, with 12 IPOs and 28 unicorns, though activity has slowed to 3 new investments in 2025.
• Asset Valuation Mismatch: The exit price of Blue Arrow Space shares was 1.305 billion yuan in April 2025, whereas the stake (11.063%) is now valued at over 8 billion yuan based on projected IPO valuation of 75 billion yuan.

Industry Insight

• Real Estate-Tech Decoupling: The incident exemplifies the "forced exit" phenomenon where distressed real estate developers are priced out of their tech investments, transferring value to state-owned enterprises (like Hefei Jianshang) or missing out on the AI/semiconductor super-cycle.
• Valuation Volatility: The jump from 300 billion to 2 trillion yuan valuation for Changxin indicates extreme multiple expansion driven by fundamental performance recovery, suggesting that early-stage tech investors must align exit timing with sector-specific earnings cycles, not just parent company liquidity needs.
• CVC Risk Management: Corporate venture arms must isolate their tech portfolios from the parent company’s financial contagion risks; Country Garden’s inability to hold its winners due to "delivery guarantee" capital requirements highlights a structural flaw in CVC funding models dependent on parent cash flows.

FAQ

Q: Why did Country Garden sell its stake in Changxin Technology?
A: Country Garden sold its stake to address a severe liquidity crisis and to raise funds for its "housing delivery guarantee" (baojiaolou) obligations after incurring a 32.835 billion yuan loss in 2024 and facing a cash flow shortage.

Q: What is the current valuation of Changxin Technology compared to when it was sold?
A: The pre-IPO valuation was near 300 billion yuan, but based on Q1 2026 financial results, institutions estimate the new valuation could reach approximately 2 trillion yuan, representing a massive re-rating since the 2024 sale.

Q: What other high-value tech assets did Country Garden divest recently?
A: Country Garden has divested stakes in Blue Arrow Space (sold for 1.305 billion yuan in 2025), Dreame Technology (exited in 2024), and Beike, among others, to conserve cash for core real estate operations.